Filing Details

Accession Number:
0001391390-10-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-01 12:00:00
Reporting Period:
2010-02-26
Filing Date:
2010-03-01
Accepted Time:
2010-03-01 15:55:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1391390 Boise Inc. BZ Papers & Allied Products (2600) 208356960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1122443 Madison Dearborn Capital Partners Iv Lp C/O Boise Cascade Holdings, L.l.c.
1111 West Jefferson Street, Suite 300
Boise ID 83728
No No Yes No
1249306 Madison Dearborn Partners Iv Lp C/O Boise Cascade Holdings, L.l.c.
1111 West Jefferson Street, Suite 300
Boise ID 83728
No No Yes No
1317436 Boise Cascade Holdings, L.l.c. 1111 West Jefferson Street
Suite 300
Boise ID 83728
No No Yes No
1326831 Forest Products Holdings, L.l.c. C/O Boise Cascade Holdings, L.l.c.
1111 West Jefferson Street, Suite 300
Boise ID 83728
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-26 273,482 $4.90 15,547,328 No 4 S Direct
Common Stock Disposition 2010-02-26 10,311,910 $4.70 5,235,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Sales Plan adopted on December 14, 2009, by the Reporting Person pursuant to Rule 10b5-1, with sales commencing on February 16, 2010.
  2. This transaction was effected pursuant to Issuer's Shelf Registration Statement, File Number 333-155595.
  3. Boise Cascade Holdings, L.L.C. ("BCH") is the record owner of the common shares set forth herein. The shares held by BCH may be deemed to be beneficially owned by Forest Products Holdings, L.L.C. ("FPH"), which is controlled by Madison Dearborn Capital Partners IV, L.P. ("MDCP IV"). Madison Dearborn Partners IV, L.P. ("MDP IV"), is the general partner of MDCP IV.